3rd November 2008
Oxford Instruments plc
BOARD CHANGE
Oxford Instruments plc announces that Mr. Steven Parker has given notice of his intention to resign from the Group in order to pursue a new career direction and accordingly it has been agreed that he will retire from the Board with effect from 13th November 2008. Nigel Keen, Chairman said "I should like to thank Steve for his contribution to Oxford Instruments over the past six years and to wish him continued success in the future".
Ends
Enquiries:
Oxford Instruments plc |
Tel: 01865 393200 |
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director
Hogarth Partnership Limited |
Tel: 020 7357 9477 |
Rachel Hirst / Andrew Jaques / Ian Payne
Notes to Editors
Oxford Instruments designs, supplies and supports high-technology tools, processes and solutions with a focus on physical science, bioscience, environmental and industrial research and applications. It provides solutions needed to advance fundamental nanoscience research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 40 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.
The first technology business to be spun out from Oxford University over forty years ago, Oxford Instruments is now a global company with over 1400 staff worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the Physical Science and Bioscience sectors.
This involves the combination of core technologies in areas such as low temperature and high magnetic field environments, Nuclear Magnetic Resonance, X-ray electron and optical based metrology, and advanced growth, deposition and etching. Our products, expertise, and ideas address global issues such as energy, environment, terrorism and health and are part of the next generation of telecommunications, energy products, environmental measures, security devices, drug discovery and medical advances.